Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Lecrubier

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Psychiatry|August 26, 1998
The impact of comorbidity on the treatment of panic disorderY Lecrubier
L'Encephale|April 1, 1997
[Schizophrenia, from classification to dimensions: value of longitudinal studies]Y Lecrubier
Current Medical Research and Opinion|November 7, 2002
Amisulpride: progress and outcomesY Lecrubier
Acta Psychiatrica Scandinavica. Supplementum|December 21, 2002
How do you define remission?Y Lecrubier
The Journal of Clinical Psychiatry|November 12, 1998
Comorbidity in social anxiety disorder: impact on disease burden and managementY Lecrubier
L'Encephale|December 1, 1991
[Therapeutic effect of amoxapine. A pragmatic study]Y Lecrubier
L'Encephale|June 1, 1994
[Treatment of subsyndromes, or: consultation for chemotherapy of subsyndromes of depressive states]Y Lecrubier
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Improved ability to identify symptoms of major depressive disorder (MDD) in general practiceY Lecrubier
European Psychiatry : the Journal of the Association of European Psychiatrists|March 9, 2007
The Ham D(6) is more homogenous and as sensitive as the Ham D(17)Y Lecrubier, P Bech
Acta Psychiatrica Scandinavica|February 1, 1997
Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study InvestigatorsY Lecrubier, R Judge
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Psychiatry|August 26, 1998
The impact of comorbidity on the treatment of panic disorderY Lecrubier
L'Encephale|April 1, 1997
[Schizophrenia, from classification to dimensions: value of longitudinal studies]Y Lecrubier
Current Medical Research and Opinion|November 7, 2002
Amisulpride: progress and outcomesY Lecrubier
Acta Psychiatrica Scandinavica. Supplementum|December 21, 2002
How do you define remission?Y Lecrubier
The Journal of Clinical Psychiatry|November 12, 1998
Comorbidity in social anxiety disorder: impact on disease burden and managementY Lecrubier
L'Encephale|December 1, 1991
[Therapeutic effect of amoxapine. A pragmatic study]Y Lecrubier
L'Encephale|June 1, 1994
[Treatment of subsyndromes, or: consultation for chemotherapy of subsyndromes of depressive states]Y Lecrubier
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Improved ability to identify symptoms of major depressive disorder (MDD) in general practiceY Lecrubier
European Psychiatry : the Journal of the Association of European Psychiatrists|March 9, 2007
The Ham D(6) is more homogenous and as sensitive as the Ham D(17)Y Lecrubier, P Bech
Acta Psychiatrica Scandinavica|February 1, 1997
Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study InvestigatorsY Lecrubier, R Judge
Pageof 13